hero_shot_041918_silhouette

Next Generation in Protein Characterization

RedShiftBio’s AQS3pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018

TASIA showcases the technologies driving the advancement of measurement science.

AQS3_TM_pro-75

The Next Generation in Protein Characterization

The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:

Aggregation | Quantitation | Stability | Structure | Similarity

See change in your protein, in your workflow, and in your efficiency.

Visit the product page to learn more.

Watch our latest webinar replay

Load samples and walk away.

The widest concentration range to characterize biotherapeutics.

Generate precise, high sensitivity data.

Analyze and understand protein behavior.

RedShiftBio™

RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Read More

Awards

TAS-footer
prism-logo-footer

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio™,  See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.

Class 1 Laser Device Complies with 21 CFR Chapter 1, Subchapter J, Part 1040.10